bosentan anhydrous has been researched along with Amentia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jaggi, AS; Sharma, B; Singh, G; Singh, N | 1 |
| Prakash, A; Singh, M | 1 |
2 other study(ies) available for bosentan anhydrous and Amentia
| Article | Year |
|---|---|
Efficacy of bosentan, a dual ETA and ETB endothelin receptor antagonist, in experimental diabetes induced vascular endothelial dysfunction and associated dementia in rats.
Topics: Acetylcholinesterase; Animals; Blood Glucose; Bosentan; Brain; Dementia; Diabetes Mellitus, Experimental; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelium, Vascular; Glutathione; Male; Nitrates; Nitrites; Rats; Rats, Wistar; Streptozocin; Sulfonamides | 2014 |
Possible role of endothelin receptor against hyperhomocysteinemia and β-amyloid induced AD type of vascular dementia in rats.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Bosentan; Brain; Dementia; Dementia, Vascular; Endothelins; Endothelium, Vascular; Hyperhomocysteinemia; Lipid Peroxidation; Male; Maze Learning; Memory; Methionine; Mitochondria; Oxidative Stress; Rats; Rats, Wistar; Receptors, Endothelin; Sulfonamides | 2017 |